X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (9) 9
index medicus (9) 9
chemotherapy (7) 7
cancer (6) 6
middle aged (6) 6
oncology (6) 6
breast neoplasms - drug therapy (5) 5
male (5) 5
adult (4) 4
breast cancer (4) 4
breast neoplasms - pathology (4) 4
risk factors (4) 4
aged (3) 3
breast neoplasms - metabolism (3) 3
cell line, tumor (3) 3
neoadjuvant therapy (3) 3
research (3) 3
survival (3) 3
time factors (3) 3
animals (2) 2
antiemetics - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
breast neoplasms - genetics (2) 2
cancer patients (2) 2
care and treatment (2) 2
comorbidity (2) 2
complications and side effects (2) 2
development and progression (2) 2
dexamethasone (2) 2
dexamethasone - administration & dosage (2) 2
double-blind method (2) 2
drug therapy (2) 2
emetogenic chemotherapy (2) 2
gastroenterology & hepatology (2) 2
health care sciences & services (2) 2
identification (2) 2
medicine (2) 2
medicine & public health (2) 2
mice (2) 2
nausea (2) 2
nausea - chemically induced (2) 2
nausea - prevention & control (2) 2
neoplastic stem cells - metabolism (2) 2
nursing (2) 2
ondansetron - administration & dosage (2) 2
pain medicine (2) 2
pathological complete response (2) 2
prevention (2) 2
radiation-therapy (2) 2
rehabilitation (2) 2
rehabilitation medicine (2) 2
research article (2) 2
severity of illness index (2) 2
skin and connective tissue diseases (2) 2
trastuzumab (2) 2
trial (2) 2
vomiting (2) 2
vomiting - chemically induced (2) 2
vomiting - prevention & control (2) 2
adjuvant tamoxifen (1) 1
adolescent (1) 1
aged patients (1) 1
allergy (1) 1
anemia - diagnosis (1) 1
anemia - epidemiology (1) 1
anemia - therapy (1) 1
antagonist aprepitant (1) 1
anthracycline (1) 1
anthracyclines (1) 1
anti-emetic (1) 1
antibodies, monoclonal, humanized - pharmacology (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antiemetics - adverse effects (1) 1
antiemetics - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, phytogenic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
aprepitant (1) 1
article subject (1) 1
assessing tumor response (1) 1
assessment scale (1) 1
biochemistry & molecular biology (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
body mass index (1) 1
bone neoplasms - secondary (1) 1
brain-tumors (1) 1
breast neoplasms - surgery (1) 1
cancer surgery (1) 1
cancer therapies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e17582 - e17582
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2/2017, Volume 25, Issue 2, pp. 459 - 464
Journal Article
Oncology, ISSN 0030-2414, 03/2018, Volume 94, Issue 3, pp. 149 - 160
Journal Article
Molecular Cell, ISSN 1097-2765, 08/2012, Volume 47, Issue 4, pp. 570 - 584
Journal Article
Journal of the Medical Association of Thailand, ISSN 0125-2208, 02/2013, Volume 96, Issue 2, pp. S257 - S261
A 52-year-old man suffered from visual disturbance for 5 months. He then developed malaise, constipation and anorexia with significant weight loss. Physical... 
Hypopituitarism | Renal cell carcinoma | Pituitary metastasis | Kidney Neoplasms - pathology | Male | Pituitary Neoplasms - secondary | Carcinoma, Renal Cell - secondary | Humans | Middle Aged
Journal Article
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, ISSN 0125-2208, 2009, Volume 92, pp. S110 - 118
Causes of anemia in cancer patients are multifaceted and include such factors as nutritional deficiency anemia, anemia of malignancy and treatment-related... 
Anemia - epidemiology | Humans | Middle Aged | Risk Factors | Anemia - diagnosis | Hospitals, University | Anemia - therapy | Male | Antineoplastic Agents - therapeutic use | Thailand | Young Adult | Neoplasms - complications | Neoplasms - therapy | Adolescent | Adult | Female | Aged | Neoplasms - pathology | Cohort Studies
Journal Article
International journal of cancer, ISSN 0020-7136, 08/2019
Gender disparities in scientific publications have been identified in oncological research. Oral research presentations at major conferences enhance visibility... 
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 4/2012, Volume 20, Issue 4, pp. 849 - 855
Ondansetron plus dexamethasone are standard antiemetic agents for highly emetogenic chemotherapy. Metoclopramide is a dopamine antagonist, which may enhance... 
Pain Medicine | Nursing | Rehabilitation Medicine | Anti-emetic | Medicine & Public Health | Oncology | Emetogenic chemotherapy | Metoclopramide | Nursing Management/Nursing Research | IMPACT | ANTAGONIST APREPITANT | CHEMOTHERAPY-INDUCED NAUSEA | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | HEALTH CARE SCIENCES & SERVICES | DELAYED EMESIS | PREVENTION | REHABILITATION | Nausea - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Time Factors | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Antiemetics - adverse effects | Female | Drug Therapy, Combination | Vomiting - prevention & control | Severity of Illness Index | Dexamethasone - administration & dosage | Double-Blind Method | Ondansetron - administration & dosage | Metoclopramide - administration & dosage | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Metoclopramide - therapeutic use | Ondansetron - therapeutic use | Metoclopramide - adverse effects | Cisplatin - adverse effects | Quality of Life | Ondansetron - adverse effects | Medicine | Prokinetic agents | Chemotherapy | Dexamethasone | Central nervous system depressants | Practice | Clinical trials | Dosage and administration | Nausea | Ondansetron | Cancer | Preventive medicine | Vomiting
Journal Article
Molecular cell, ISSN 1097-2765, 8/2012, Volume 47, Issue 4, pp. 570 - 584
Although inactivation of the PTEN gene has been implicated in the development of resistance to the HER2 targeting antibody trastuzumab, the mechanisms... 
Journal Article
Asian Pacific journal of cancer prevention : APJCP, 06/2019, Volume 20, Issue 6, p. 1727
Non-squamous cell carcinoma of the head and neck (HNnSCCA) is a rare tumor. Surgery is the standard treatment for resectable non-metastatic patients.... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.